Restrictions on the prescribing of dextropropoxyphene (DXP) – effects on sales and cases
of fatal poisoning. Ulf Jonasson & Birgitta Jonasson,
Report written on behalf of Rättsmedicinalverket (National Board of Forensic Medicine) and Läkemedelsverket (Medical Products Agency) in co-operation with Riksförsäkringsverket (National Social Insurance Board) and Giftinformationscentralen (Swedish Poisons Information Centre)
Inga kommentarer:
Skicka en kommentar